What you need to know April 09, 2024 This small-cap has partnered with a big defense contractor *sponsored by Lifewater Media Please join hundreds of traders for LIVE TRADING action all day long in the [Market Masterâs trading room](. Talk about todayâs focus stocks, plus dozens of other breaking stocks that are moving during the day. Be the best prepared trader on the Street! FOCUS LISTð ACRV - Up over 50% in the pre-market after announcing $130 million in private placement financing BPTS - Up over 40% in pre after reporting financial results update on business activities  LASE - Up over 130% in pre after securing order from L3Harris Technologies for LaserTower Marking & Engraving System *sponsored by Lifewater Media One of our favorite stocks is back in the spotlight again today, and you should take notice. Pull up Kartoon Studios (TOON) on your platform right away. Just a few weeks ago, TOON made a blistering 50%+ move after it re-established trading above the 20-hour level and fired off a big hourly âGOâ signal, as you can see below. If this chart wasnât enough, just moments ago, TOON [released]( what I think was their strongest earnings report â EVER! When you look at the numbers this company is putting up right now, I donât think there is any argument they are not just turning the corner. Rather, they are charging full steam ahead. Make sure you keep TOON on the top of your watchlist today! *Sponsored content/paid advertisement. This investment involves substantial risk. Please read our full disclosure below, or [click here](, for a detailed discussion of risks and atypical results. HOTLISTð¥ ACRV - Up over 70% in the pre-market after announcing $130 million in private placement financing Acrivon Therapeutics, Inc. (ACRV) is a clinical stage biopharmaceutical company that engages in developing oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. In the pre-market this morning, the [company announced]( that it would be raising $130 million in a private placement financing. ACRV entered into a securities purchase agreement with certain existing and new accredited investors to issue and sell an aggregate of 8,235,000 shares of its common stock at a price of $8.50 per share, a premium to the closing price on April 8, 2024, and pre-funded warrants to purchase up to an aggregate of 7,060,000 shares of common stock at a purchase price of $8.499 per pre-funded warrant, through a private investment in public equity (âPIPEâ) financing. The pre-funded warrants will have an exercise price of $0.001 per share of common stock, be immediately exercisable and remain exercisable until exercised in full. The closing of the financing is expected to occur on April 11, 2024, subject to customary closing conditions. The stock traded up over 50% in the pre-market in reaction to the news. $9.50 was a resistance area and now becomes a potential support level. Above it, targets to the upside are $10 and then the pre-market high at $10.43. Beyond that $11, $12 and $13 come into play. Below $9.50, targets to the downside are $9, $8.60, $7 and then a gap fill at $5.91. BPTS - Up over 40% in the pre-market after reporting financial results update on business activities Biophytis S.A. (BPTS) is a clinical-stage biotechnology company that focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. In the after-hours yesterday the [company reported]( financial results and an update on its business activities. The annual loss for 2023 was reduced YoY and came in at â¬17 million at December 31, 2023 vs â¬24.2 million at December 31, 2022. A significant reduction in R&D expenditure was linked to the completion of clinical trials for the COVA and SARA programmes. The change in the financial result is essentially due to the revaluation of financial debts in accordance with IFRS 9. BPTS announced it had also obtained authorization to initiate a phase 3 SARA-31 trial in the United States and Belgium in sarcopenia, a disease that is still poorly understood but very common among the elderly and currently untreated. BPTS is actively seeking global or regional pharmaceutical company partners to co-finance the phase 3 studies required to file a marketing authorization and to market BIO101 (20-hydroxyecdysone) in these two indications. The stock traded up over 40% in the pre-market in reaction to the financial results and business update. The $0.47 area acted as support in the after-hours and the pre-market and now becomes a potential resistance level. Above it, targets to the upside are $0.52, $0.60, and then the pre-market high at $0.79. LASE - Up over 130% in pre after securing order from L3Harris Technologies for LaserTower Marking & Engraving System Laser Photonics Corporation (LASE) provides integrated laser blasting solutions for corrosion control, rust removal, de-coating, pre- and post-welding, laser cleaning, and surface conditioning in the Americas and internationally. In the pre-market this morning the [company announced]( that it received an order for its LaserTower COMPACT marking and engraving system from L3Harris Technologies, Inc. L3Harris, one of the largest long-time defense contractors in the United States. L3Harris will use LPCâs LaserTower COMPACT system at its semiconductor division in Palm Bay, Florida. The company focuses on command and control systems, precision munitions, avionics and electronic systems, and other specialized equipment for the government, defense and commercial sectors. LASE traded up over 130% in the pre-market in relation to the news. The $2 area was first a resistance area and then acted as a support level in the pre-market. Above it, targets to the upside are $2.24, $2.38 and then the pre-market high at $2.48. Beyond that, $3 and $3.50 come into play. Below $2, targets to the downside are $1.90, $1.80, $1.72 and then a gap fill at $1.43. MARKET NEWS ð° P.S. Make sure you text âRAGEâ to (888) 404-5747 to get all of our latest HOT STOCK ideas! Questions or concerns about our products? Email [Support@360wallstreet.io]( © Copyright 2022, RagingBull *PAID ADVERTISEMENT. RagingBull has currently been paid seventeen thousand five hundred dollars by ach bank transfer by Lifewater Media for advertising Kartoon Studio, Inc for a one day advertising program on april 9, 2024. RagingBull was previously been paid sixteen thousand dollars by ach bank transfer by Lifewater Media for advertising Kartoon Studio, Inc for a one day advertising program. RagingBull has previously been paid twenty five thousand dollars by ach bank transfer by Lifewater Media for advertising Kartoon Studio, Inc from a period beginning on July 31, 2023 through August 1, 2023 of the same year, as well as fifteen thousand dollars by ach bank transfer by Lifewater Media for advertising Kartoon Studio, Inc (formerly, Genius Brands International, INC) from a period beginning on June 21, 2023 through June 22, 2023 of the same year. As a result of this advertisement and other marketing efforts, RagingBull may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of this advertisement, the owners of Raging Bull do not hold a position in Kartoon Studio, Inc (formerly, Genius Brands International, INC). This advertisement and other marketing efforts may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of Kartoon Studio, Inc, increased trading volume, and possibly an increased share price of the Kartoon Studio, Inc securities, which may or may not be temporary and decrease once the marketing arrangement has ended. As of the date of the issuance of this advertisement, the owners of Raging Bull do not hold a position in Kartoon Studio, though they reserve the right to buy or sell shares in the covered company at any time following the dissemination of this communication. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. This advertisement is for educational and informational purposes only. All material information contained in this advertisement is based on information generally available to the public, which public information is believed to be reliable and accurate. Nevertheless, Raging Bull cannot guarantee the accuracy or completeness of the information. This advertisement does not purport to be a complete analysis of any companyâs financial position. This advertisement or any statements made in it is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. The statements made in this advertisement should NOT be relied upon for purposes of investing in the companies mentioned in this advertisement, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security mentioned in this advertisement or in any other security or strategy. It is strongly recommended that you consult a licensed or registered professional before making any investment decision. SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in any securities of the companies mentioned in this advertisement should do so with caution. Investing or transacting in any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers of this advertisement bear responsibility for their own investment research and decisions, and should use information from this advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money investing or trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments. Our reports/releases are a commercial advertisement and are for general information purposes ONLY. A portion of our business is engaged in the marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use. A portion of RagingBullâs business model is to receive financial compensation to promote public companies. To conduct investor relations advertising, marketing and publicly disseminate information not limited to our websites, email, SMS, push notifications. This compensation is a major conflict of interest in our ability to provide unbiased reporting. Therefore, this communication should be viewed as a commercial advertisement only. Note, we periodically conduct interviews and issue stock alerts that we are not compensated for. These are purely for the purpose of company awareness, and to generate subscription revenues. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Frequently, companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the corporate awareness program ceases. Our emails may contain forward-looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our website / media webpage. The information in our website / media webpage is believed to be accurate and correct but has not been independently verified and is not guaranteed to be correct. NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Raging Bull, or any of their owners, employees or independent contractors is not currently registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. USE OF FORWARD-LOOKING STATEMENTS. Certain statements made in this advertisement may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements often include words such as âbelieves,â âanticipates,â âestimates,â âexpects,â âprojects,â âintends,â or other similar expressions of future performance or conduct. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve many risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. There is no guarantee that past performance will be indicative of future results. Raging Bull does not undertake an obligation to update forward-looking statements in light of new information or future events. Readers can and should review all public SEC filings made by the companies profiled in the Advertisements at https: // www. sec. gov/edgar/searchedgar /companysearch WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers mentioned in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. TRADEMARKS. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of the advertisement is made or implied. [tw]( Update your email preferences or unsubscribe [here]( © 2024 360 WallStreet 62 Calef Hwy. #233
lee, NH 03861, United States of America